NexgenRx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:NXG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
01 Oct 24	BuyCA$3,480	Paul Crossett	Individual	14,500	CA$0.24
17 Sep 24	BuyCA$5,000	Paul Crossett	Individual	20,000	CA$0.25
13 Sep 24	BuyCA$3,750	Paul Crossett	Individual	15,000	CA$0.25
22 Aug 24	BuyCA$120	Paul Crossett	Individual	500	CA$0.24
14 Aug 24	BuyCA$5,000	Paul Crossett	Individual	20,000	CA$0.25
07 Aug 24	BuyCA$2,600	Paul Crossett	Individual	10,000	CA$0.26
07 Aug 24	BuyCA$1,300	Paul Crossett	Individual	5,000	CA$0.26
02 Aug 24	BuyCA$6,210	Paul Crossett	Individual	23,500	CA$0.27
17 Jun 24	BuyCA$31,008	Kelly Elher	Individual	114,000	CA$0.27
17 Jun 24	SellCA$5,600	Proteus Capital Corp, Asset Management Arm	Company	20,000	CA$0.28
17 Jun 24	SellCA$8,400	Ombas	Company	30,000	CA$0.28
13 Jun 24	SellCA$21,312	Kelly Elher	Individual	77,500	CA$0.27
24 May 24	BuyCA$33,600	Ronald Loucks	Individual	120,000	CA$0.28
23 May 24	BuyCA$13,860	Paul Crossett	Individual	49,500	CA$0.28

Insider Trading Volume

Insider Buying: NXG insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NXG?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	300,000	0.422%
Individual Insiders	26,441,788	37.2%
General Public	44,375,344	62.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 7 shareholders own 37.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.1%	Paul Crossett	14,256,638	CA$3.6m	0.1%	no data
10.5%	Ronald Loucks	7,455,108	CA$1.9m	0%	no data
5%	Charles Burns	3,555,667	CA$888.9k	0%	no data
0.88%	Thomas Corcoran	625,375	CA$156.3k	0%	no data
0.63%	Kelly Elher	449,000	CA$112.2k	0%	no data
0.42%	Serpent River Power Corporation	300,000	CA$75.0k	0%	no data
0.14%	Randolf McGlynn	100,000	CA$25.0k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 09:26
End of Day Share Price	2024/12/16 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NexgenRx Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution